Correlation Between MediciNova and Akanda Corp
Can any of the company-specific risk be diversified away by investing in both MediciNova and Akanda Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Akanda Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Akanda Corp, you can compare the effects of market volatilities on MediciNova and Akanda Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Akanda Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Akanda Corp.
Diversification Opportunities for MediciNova and Akanda Corp
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Akanda is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Akanda Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akanda Corp and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Akanda Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akanda Corp has no effect on the direction of MediciNova i.e., MediciNova and Akanda Corp go up and down completely randomly.
Pair Corralation between MediciNova and Akanda Corp
Given the investment horizon of 90 days MediciNova is expected to under-perform the Akanda Corp. But the stock apears to be less risky and, when comparing its historical volatility, MediciNova is 1.54 times less risky than Akanda Corp. The stock trades about -0.27 of its potential returns per unit of risk. The Akanda Corp is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Akanda Corp on October 22, 2024 and sell it today you would lose (6.00) from holding Akanda Corp or give up 3.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
MediciNova vs. Akanda Corp
Performance |
Timeline |
MediciNova |
Akanda Corp |
MediciNova and Akanda Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Akanda Corp
The main advantage of trading using opposite MediciNova and Akanda Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Akanda Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akanda Corp will offset losses from the drop in Akanda Corp's long position.MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Akanda Corp vs. China SXT Pharmaceuticals | Akanda Corp vs. Petros Pharmaceuticals | Akanda Corp vs. GelStat Corp | Akanda Corp vs. Shuttle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |